Differentiating renal pelvic cancer from renal cell carcinoma with 18-fluorodeoxyglucose positron emission tomography-computed tomography.

Dursun M., Ozbek E., Otunctemur A., Besiroglu H.

Journal of cancer research and therapeutics, cilt.17, sa.4, ss.901-905, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4103/jcrt.jcrt_217_16
  • Dergi Adı: Journal of cancer research and therapeutics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.901-905
  • Anahtar Kelimeler: 18-fluorodeoxyglucose positron emission tomography, renal cell carcinoma, maximum standardized uptake value, UPPER URINARY-TRACT, UROTHELIAL CARCINOMA, DIAGNOSIS, NEOPLASMS, URETER, RISK, PET, CT
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background: The differential diagnosis of pelvis renalis cancer (PRC) from renal cell cancer (RCC) is difficult. Because of that, in this study, we compared the standardized uptake value (SUV) with positron emission tomography-computed tomography (PET-CT) of the RCC and PRC.